Further Group

What Further Group does

Further Group is a Madrid-headquartered, private (PE-backed by AnaCap since 2022), digital-first insurance specialist that designs and administers serious illness insurance products — most notably covering cancer, cardiac surgery, neurosurgery, and organ transplants — for insurers and large multinational employers across more than 30 countries. Founded in 2012 and operating through regional offices in EMEA (Madrid), China (Beijing), and Southeast Asia (Singapore), the company combines proprietary technology (including the acquired Trustedoctor digital platform for second medical opinions and international medical access) with curated networks of leading hospitals and specialists to deliver precision medicine and serious illness coverage as turnkey add-ons to existing group life, critical illness, and income protection policies.

The product portfolio is anchored by Precision CancerCare™, a precision medicine platform that coordinates genomic testing, molecular profiling, and personalized treatment recommendations through a Medical Expert Board, and is supported by modular add-ons: Critical Care (Zurich-embedded), CancerSecure (Germany via MRH Trowe), Precision CancerCare GAP (China via Ping An Life), Precision Cancer Service (UK via Healix), Second Medical Opinion, and the Cancer Risk Assessment Tool. Brand assets include registered trademarks on Precision CancerCare™, Critical Care, CancerSecure, and Trustedoctor, plus ISO 9001, ISO/IEC 27001, and ISO/IEC 27701 certifications and UN Global Compact / EcoVadis recognition.

Further generates revenue by designing, administering, and embedding its insurance solutions — primarily through insurance premium flows on group policies, reinsurance-supported product design, and channel partnerships with international brokers (MRH Trowe, MAXIS GBN). Pricing is bespoke, contract-based, and undisclosed. Go-to-market is enterprise field sales supplemented by channel resellers, with no direct-to-consumer distribution. The company lists 85+ insurer partners and 200+ organizational customers (one source references 300+), supported by a leadership team with deep insurance, reinsurance, and medical-services credentials (Aviva, RSA, Zurich, IBM, McKinsey, Mercer, Best Doctors, Marsh, AIG).

Name

Further Group

Legal name

Further Underwriting International, S.L.U.

Website

https://wegofurther.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

51–100 employees

Short description

Further Group is a Madrid-based, PE-backed digital specialist that designs and administers serious illness insurance products and precision medicine services — covering cancer, cardiac, neurosurgery, and organ transplant care — for insurers and large multinational employers across more than 30 countries.

Ownership category

akta.pro rank

Product category

Specialty Health Insurance

NAICS

Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292), Direct Health and Medical Insurance Carriers (524114), Direct Life, Health, and Medical Insurance Carriers (52411)

SIC

Accident & Health Insurance (6321), Life Insurance (6311), Services-Misc Health & Allied Services, Nec (8090)

akta.pro primary industry

Policy Administration, Underwriting & Rating Platforms (Core Insurance SaaS) (FSAGAGAB)

akta.pro secondary industries

Combined Critical Illness + Hospital Indemnity Policies (FSAIAKAC), Specified Disease Hospital Indemnity (e.g., Cancer Hospital Indemnity) (FSAIAKAI), Care Management & Coordination Platforms (case/disease management workflows) (HLACAHAD)

Keywords

• Serious illness insurance
• Precision medicine solutions
• Employee benefits design
• Cancer insurance products
• International medical access

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Insurance Product Premiums: Further designs and administers serious illness insurance products — including Critical Care, Critical Illness, and Precision CancerCare — sold to employers (as employee benefits) and insurers (as add-on coverage). Revenue is generated through insurance premiums collected from group policies, with Further acting as a product developer, administrator, and service coordinator.
2. Reinsurance Partnerships: Strong relationships with reinsurers support the actuarial pricing and risk capacity for Further's insurance products. Reinsurance partnerships enable product design, risk-sharing, and financial stability.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Further Group designs and distributes turnkey serious illness insurance solutions — including Precision CancerCare™, Critical Care, CancerSecure, Second Medical Opinion, and the Cancer Risk Assessment Tool — that provide insured employees with affordable, timely access to world-leading medical experts, advanced treatments, and international hospital networks. The company develops these products and embeds them into the portfolios of insurance companies (e.g., Zurich, Ping An Life) or distributes them via international brokers to large multinational employers across 30+ countries.

Product overview

Further Group is a digital-first specialist in designing and developing medical niche products and insurance service solutions for serious illnesses. Founded in 2012, the company operates through a portfolio approach combining its core Precision CancerCare™ platform with modular add-on products including CancerSecure, Critical Care, Second Medical Opinion, and the Cancer Risk Assessment Tool. The acquired Trustedoctor digital platform enables digital transformation, while partnerships with global insurers (Zurich, Ping An Life, MRH Trowe, Healix) extend product distribution. The portfolio serves insurers and employers across 30+ countries, providing turnkey solutions for cancer treatment, cardiac surgery, neurosurgery, and organ transplants with access to international medical expertise.

Differentiator

Problem solved

Functional benefit

Brands

• Precision CancerCare: Precision medicine approach to cancer treatment providing optimized treatments, better medical outcomes, and improved quality of life.
• CancerSecure
• Critical Care
• Precision Cancer Service
• Trustedoctor

Products and services

• Precision CancerCare™ Advanced precision medicine platform for cancer treatment providing optimized cancer treatments, better medical outcomes, and improved quality of life through personalized treatment plans based on genetic profiling of tumors. Sold to insurers and employers as part of serious illness coverage.
• CancerSecure Insurance solution providing personalized cancer treatment plans and access to the latest therapies through a global network of leading oncology centers, including advanced genetic testing and expert medical board interpretation. Distributed in Germany via MRH Trowe.
• Critical Care Insurance coverage for serious illnesses that covers treatment costs plus travel and accommodation for employees requiring cancer treatment, cardiac surgery, neurosurgery, or organ transplant at leading international hospitals. Co-developed with Zurich International.
• Second Medical Opinion Medical second opinion service integrated with precision medicine, providing access to global specialist networks, advanced genomic testing, and personalized treatment recommendations for cancer diagnoses.
• Cancer Risk Assessment Tool Fully digital prevention tool providing personalized cancer risk assessment based on lifestyle, genetic, and environmental factors, with tailored evidence-based recommendations and screening guidance.
• Precision CancerCare GAP Insurance gap product enabling access to cutting-edge treatments and targeted oncology drugs unavailable in China through international medical centers, with full travel and accommodation support.
• Precision Cancer Service Comprehensive oncology care pathway supporting employees diagnosed with advanced, rare, or treatment-resistant cancers through molecular profiling, expert medical board evaluation, and personalized treatment planning.

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Healix HealthcoreStrategic or Co-development Partner · 4 November 2025Launched Precision Cancer Service in partnership with Healix Health, enhancing their oncology care pathway with advanced genomic testing and personalized treatment recommendations. Targeted at UK employees, covering stage III/IV cancers, rare cancers, CUP, and treatment-resistant cancers.
• Ping An Life InsurancecoreStrategic or Co-development Partner · 22 October 2025Launched Precision CancerCare GAP (PCC Gap) program in China with Ping An Life, one of China's leading life insurers. Enables access to genomic testing and international cancer treatment for Chinese policyholders, complementing domestic health insurance coverage.
• MRH TrowecoreChannel Partner/ Reseller/ Distributor · 2 July 2025German insurance broker (1,700+ employees, top-10 in Germany) distributing CancerSecure — a precision medicine cancer solution — to German employer clients. MRH Trowe focuses on individual and sustainable insurance solutions for business and private clients.
• Zurich Insurance / Zurich InternationalcoreStrategic or Co-development Partner · 26 June 2025Launched Critical Care insurance product with Zurich International (Isle of Man) — covering cancer, cardiac, neurosurgery, and organ transplant treatment costs plus travel and accommodation at leading international hospitals. Also partnered on Second Medical Opinion service with Precision CancerCare™ and a Cancer Risk Assessment tool. Available to Zurich UK Group Life, Critical Illness, and Income Protection policyholders.
• MAXIS Global Benefits NetworkminorGTM or Marketing PartnerCollaboration with MAXIS GBN (global employee benefits network) includes participation in annual Maxis Global Forum and joint analysis of cancer claims data from 43 countries covering 1.3M+ lives. Further contributes expertise in serious illness insurance and precision medicine to MAXIS's corporate client base.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Best Doctors (acquired by Teladoc Health): Best Doctors pioneered the medical second opinion and expert medical access model, including for cancer cases, and was acquired by Teladoc Health. Highly comparable to Further's Trustedoctor/SMO capability and to the company's design of cancer-focused insurance add-ons. Notably, Further's Russia/CIS Director previously worked at Best Doctors.
• International SOS: Global medical assistance, evacuation, and international medical network provider widely embedded in group insurance and corporate benefits. Directly comparable to Further's cross-border serious illness treatment coordination and travel/accommodation benefits within Critical Care.
• Collinson Group: Privately owned group operating insurance assistance, travel health, and patient-safety/loyalty programs with international medical networks. Closely comparable to Further, including talent overlap - Further's CLO previously built Collinson's global legal function.
• Healix Health: UK health services and corporate health benefits provider offering global medical case management, second medical opinions, and occupational health. Direct partner of Further (joint Precision Cancer Service) and operates in the same niche of clinical oversight for serious illness claims.
• MSH International: Specialist in international health insurance design and administration for multinational employers and individuals, including serious illness cover. Highly comparable to Further; notably, Further's Greater China Chairwoman previously worked at MSH.

Broad incumbents

• Allianz Partners: Global assistance, health, and travel insurance line of Allianz that embeds serious illness, evacuation, and second opinion cover into its international health and life products. A broader incumbent alternative to Further's white-label insurance solutions.
• Cigna Global Health / Cigna Healthcare: Major international health insurer offering cross-border cover including oncology and serious illness benefits to multinational employers. Comparable as a buyer/embedder of serious illness solutions and as a competitor building similar capabilities in-house.
• GeoBlue (BCBS licensee): Provider of international health insurance and medical assistance for globally mobile employees. Comparable in serving multinational employers with cross-border serious illness and evacuation-style benefits that overlap Further's Critical Care proposition.

Others

• MAXIS Global Benefits Network: Global employee benefits network and reinsurance pool used by insurers to deliver multinational pooling and benefits. Further is a partner; relevant peer for Further's distribution and analytic capabilities, including joint MAXIS Global Forum cancer data work.

Emerging players

• Now Health International: Tech-led international health insurance provider serving globally mobile individuals and SMEs with cross-border cover. Comparable as a digital-first specialist designing international serious illness benefits, though smaller and more consumer-leaning than Further's employer/insurer focus.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/further-underwriting-international-s-l-u

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Further Group